Stereospecific modulation of tumorigenicity by opioid antagonists.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  European Journal of Pharmacology

• Publication date

  1985-07-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(85)90350-4PMID 2995053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioids alter tumor cell growth and differentiation in vitro.

  1984cited by this paper
• Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer.

  1984cited by this paper
• Opioid antagonists inhibit the growth of metastatic murine neuroblastoma.

  1983cited by this paper
• Enkephalins as immunomodulators.

  1983cited by this paper
• Naltrexone modulates tumor response in mice with neuroblastoma.

  1983cited by this paper
• Stereoselectivity of opiate antagonists in rat hippocampus and neocortex: responses to (+) and (-) isomers of naloxone.

  1982cited by this paper
• Naloxone prolongs the survival time of mice treated with neuroblastoma.

  1981cited by this paper
• The effects of opiate antagonists on food intake are stereospecific.

  1981cited by this paper
• Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma.

  1981cited by this paper
• Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat.

  1980cited by this paper
• On the specificity of naloxone as an opiate antagonist.

  1979cited by this paper
• Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia

  1979cited by this paper
• Development of a neonatal and metastatic murine neuroblastoma model.

  1979cited by this paper
• Opiate Antagonists Can Inhibit Mammary Tumor Growth in Rats 1

  1979cited by this paper
• Failure of (+)-naloxone to antagonise responses to opioid peptides.

  1978cited by this paper
• Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.

  1978cited by this paper
• A neuroblastoma times glioma hybrid cell line with morphine receptors.

  1974cited by this paper
• A Neuroblastoma × Glioma Hybrid Cell Line with Morphine Receptors

  1974cited by this paper
• Properties of opiate-receptor binding in rat brain.

  1973cited by this paper
• Naloxone, naltrexone, and related noroxymorphones.

  1973cited by this paper
• Narcotic antagonist activity of substituted 1,2,4,5-tetrahydro-3H,3-benzazepines.

  1973cited by this paper

• Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery: A narrative review.

  2024cites this paper
• Low Doses Naltrexone: The Potential Benefit Effects for its Use in Patients with Cancer.

  2021cites this paper
• Duration of opioid receptor blockade determines biotherapeutic response.

  2015cites this paper
• Modulation of the opioid growth factor ([Met5]‐enkephalin)–opioid growth factor receptor axis: Novel therapies for squamous cell carcinoma of the head and neck

  2012cites this paper
• Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model

  2011cites this paper
• PATHWAYS TARGETED BY THE OGF-OGFr AXIS ARE DETERMINANTS IN THE PROGRESSION OF HUMAN OVARIAN CANCER

  2011cites this paper
• Encephalomyelitis : A New Paradigm for the Treatment of Multiple Sclerosis Endogenous Opioids Regulate Expression of Experimental Autoimmune

  2009cites this paper
• Endogenous opioids and multiple sclerosis

  2009cites this paper
• Signal Therapy: Propolis and Pepper Extracts as Cancer Therapeutics

  2009cites this paper
• Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis

  2009cites this paper
• Embryonal central neuroepithelial tumors: Current concepts and future challenges

  2004cites this paper
• The biology of the opioid growth factor receptor (OGFr).

  2002cites this paper
• Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.

  1991cites this paper
• Examination of the possible mediation of antineoplastic effects of opiates through the inhibition of tyrosine-specific protein kinases.

  1991cites this paper
• Opioid receptors localize to the external granular cell layer of the developing human cerebellum.

  1991cites this paper
• Opioid Peptides.

  1990cites this paper
• Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell line.

  1990cites this paper
• Non-Calcitonin Genes-Derived Neurohormonal Polypeptides in Normal and Pathologic Thyroid C Cells

  1990cites this paper
• Endogenous opioid systems regulate growth of neural tumor cells in culture.

  1989cites this paper
• Immunoreactive opioid peptides in human breast cancer.

  1989cites this paper
• Endogenous opioid systems and the regulation of dendritic growth and spine formation

  1989cites this paper
• Characterization of zeta (zeta): a new opioid receptor involved in growth.

  1989cites this paper
• Naloxone modulates body and organ growth of rats: dependency on the duration of opioid receptor blockade and stereospecificity.

  1989cites this paper
• Endogenous opioids and neural cancer: an immunoelectron microscopic study.

  1989cites this paper
• Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.

  1989cites this paper
• In vitro effects of cytosolic inhibitor and opiates on the binding of [3H]oestradiol to nuclear type II binding sites of rat uterus and hypothalamus.

  1989cites this paper
• Characterization of zeta (ζ): a new opioid receptor involved in growth

  1989cites this paper
• Regulatory peptides and amines during ontogeny and in non-endocrine cancers: occurrence and possible functional significance.

  1988cites this paper
• Characterization of opioid binding sites in murine neuroblastoma.

  1988cites this paper
• Effect of prenatal exposure to ethanol on the development of cerebral cortex: I. Neuronal generation.

  1988cites this paper
• Endogenous opioid systems and neural development: ultrastructural studies in the cerebellar cortex of infant and weanling rats.

  1988cites this paper
• Modulation of murine neuroblastoma in nude mice by opioid antagonists.

  1987cites this paper
• Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems.

  1987cites this paper
• Opioid receptors and endogenous opioids in diverse human and animal cancers.

  1987cites this paper
• Endogenous opioid systems regulate cell proliferation in the developing rat brain.

  1987cites this paper
• Endogenous opiates: 1985.

  1986cites this paper
• beta-Funaltrexamine (beta-FNA) and the regulation of body and brain development in rats.

  1986cites this paper
• Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies.

  1986cites this paper
• β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats

  1986cites this paper
• Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies

  1986cites this paper
• beta-Funaltrexamine (beta-FNA) and neural tumor response in mice.

  1985cites this paper
• β-funaltrexamine (β-FNA) and neural tumor response in mice

  1985cites this paper